Data / New clinical trials / Dermatitis, Atopic

Dermatitis, Atopic trials: 262 new since Nov 2024

Name: New Dermatitis, Atopic clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Dermatitis, Atopic clinical trials: 262 rows for $13.10, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 11 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/dermatitis-atopic, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 6, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

262 clinical studies in Dermatitis, Atopic were first posted on ClinicalTrials.gov from November 13, 2024 to November 6, 2026; 175 have an industry sponsor and 152 are recruiting or about to. The newest, NCT07920809, was posted on November 6, 2026: A Study of HSK60002 Tablets in Participants With Moderate-to-Severe Atopic Dermatitis (Haisco Pharmaceutical Group Co., Ltd.).

The request: Every new Dermatitis, Atopic clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

262New trials
175Industry sponsored
152Recruiting or not yet
November 6, 2026Latest posted

Newest trials

The newest 100 of 262, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 6, 2026	NCT07920809	A Study of HSK60002 Tablets in Participants With Moderate-to-Severe Atopic Dermatitis	Haisco Pharmaceutical Group Co., Ltd.	Phase 1	Not yet recruiting	Dermatitis Atopic	60		clinicaltrials.gov
November 6, 2026	NCT07920783	A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants	Gan & Lee Pharmaceuticals.	Phase 1	Not yet recruiting	Atopic Dermatitis	124	China	clinicaltrials.gov
November 5, 2026	NCT07919899	Pharmacokinetics, Immunogenicity and Safety of Subcutaneous Dupilumab and Berahyaluronidase Alfa (ALT-B4) Coformulation	Sanofi	Phase 3	Not yet recruiting	Dermatitis Atopic	150		clinicaltrials.gov
November 5, 2026	NCT07918586	Localized Aeroallergen Exposure in Atopic Dermatitis	Fraunhofer-Institute of Toxicology and Experimental Medicine	Not applicable	Not yet recruiting	Atopic Dermatitis	15	Germany	clinicaltrials.gov
November 5, 2026	NCT07918560	Cosmetic Efficacy Evaluation of Hydraporin AI Cream in Individuals With Atopic Dermatitis and Psoriasis	Brainfarma Industria Química e Farmacêutica S/A	Not applicable	Not yet recruiting	Atopic Dermatitis, Psoriasis	42	Brazil	clinicaltrials.gov
November 4, 2026	NCT07916480	Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis	Arcutis Biotherapeutics, Inc.	Phase 3	Recruiting	Atopic Dermatitis, Atopic Dermatitis (AD), Atopic Dermatitis (Eczema)	415	United States	clinicaltrials.gov
November 3, 2026	NCT07914088	A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis	Arjil Pharmaceuticals LLC	Phase 2	Recruiting	Dermatitis Atopic	40	Taiwan	clinicaltrials.gov
November 2, 2026	NCT07909967	Observational Analytical Validation Study of the Replior ScratchSense	Replior AB	Observational	Recruiting	Atopic Dermatitis, Pruritus, Chronic Pruritus of Unknown Origin	35	France	clinicaltrials.gov
October 29, 2026	NCT07905547	A Study to Investigate Dupixent/ Dupilumab in Adult Indian Participants With Moderate-to-severe Atopic Dermatitis	Sanofi	Phase 4	Not yet recruiting	Atopic Dermatitis	56		clinicaltrials.gov
October 29, 2026	NCT07904689	A Study of NOR-101 in Healthy Adults and Adults With Moderate-to-Severe Atopic Dermatitis	North Immunology Inc.	Phase 1	Not yet recruiting	Atopic Dermatitis (AD)	96	Australia	clinicaltrials.gov
October 29, 2026	NCT07904546	ADBest TREAT Registry	Universitätsklinikum Hamburg-Eppendorf	Observational	Recruiting	Atopic Dermatitis	5,000	Germany	clinicaltrials.gov
October 26, 2026	NCT07895615	Phase II Clinical Study to Evaluate the Efficacy and Safety of LT-002-158 Tablets in Adult Patients With Moderate-to-Severe Atopic...	Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.	Phase 2	Recruiting	Atopic Dermatitis (AD)	160	China	clinicaltrials.gov
October 21, 2026	NCT07887867	A Study to Learn About the Study Medicine Abrocitinib in People With Severe Atopic Dermatitis Who Have Switched From Other Therapies	Pfizer	Observational	Not yet recruiting	Dermatitis, Atopic	120		clinicaltrials.gov
October 14, 2026	NCT07873801	A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis	Almirall, S.A.	Phase 3	Not yet recruiting	Atopic Dermatitis	230		clinicaltrials.gov
October 2, 2026	NCT07856134	AD Treatment Optimization With Ebglyss in Real-World Practice: A Multicenter Study of Patient-Centered Outcomes	Forefront Dermatology S.C	Phase 4	Not yet recruiting	Atopic Dermatitis	250	United States	clinicaltrials.gov
September 29, 2026	NCT07848074	Abrocitinib Dose Tapering in Patients With Atopic Dermatitis	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Phase 4	Not yet recruiting	Atopic Dermatitis	100		clinicaltrials.gov
September 28, 2026	NCT07843290	A Study of JYP0066 Cream in Mild-to-Moderate Atopic Dermatitis	Guangzhou JOYO Pharma Co., Ltd	Phase 2	Not yet recruiting	Atopic Dermatitis (AD)	160		clinicaltrials.gov
September 25, 2026	NCT07842900	Oral Melatonin as Adjunctive Therapy in Adults With Atopic Dermatitis	Can Tho University of Medicine and Pharmacy	Not applicable	Not yet recruiting	Atopic Dermatitis	130		clinicaltrials.gov
September 24, 2026	NCT07839897	EFFICACY AND TOLERANCE OF AN EMOLLIENT CREAM IN SKIN OF COLOR	Pierre Fabre Dermo Cosmetique	Not applicable	Completed	Atopic Dermatitis (AD)	59	Brazil	clinicaltrials.gov
September 16, 2026	NCT07823595	Abrocitinib Treatment of Atopic Dermatitis in Children 2 to Less Than 6 Years of Age	Pfizer	Phase 3	Not yet recruiting	Atopic Dermatitis	90		clinicaltrials.gov
September 14, 2026	NCT07819071	EFFICACY AND TOLERANCE OF AN EYELID BALM IN COMBINATION WITH TACROLIMUS 0.1% IN PATIENTS WITH EYELID ATOPIC DERMATITIS	Pierre Fabre Dermo Cosmetique	Not applicable	Completed	Atopic Dermatitis (AD)	33	Poland	clinicaltrials.gov
September 10, 2026	NCT07813611	Secondary Bacterial Infections and Nasal Colonization in Scabies and Atopic Dermatitis	Istanbul Medeniyet University	Observational	Not yet recruiting	Atopic Dermatitis (AD), Scabies, Impetigo	51	Turkey (Türkiye)	clinicaltrials.gov
September 9, 2026	NCT07810777	PRA-216 Atopic Dermatitis Safety and Efficacy Study	Prana Therapies Inc	Phase 2	Recruiting	Atopic Dermatitis (AD)	39	Australia, New Zealand	clinicaltrials.gov
September 8, 2026	NCT07807228	Changes in Skin Myco- and Microbiome After Lebrikizumab Treatment	University Hospital Bispebjerg and Frederiksberg	Observational	Recruiting	Atopic Dermatitis	60	Denmark	clinicaltrials.gov
September 4, 2026	NCT07804134	Skin-in-Sight: a Longitudinal Cohort Infrastructure for Standardized Remote Monitoring and the Evaluation of Digital Care Innovations in...	Medisch Spectrum Twente	Observational	Not yet recruiting	Psoriasis, Eczema/Atopic Dermatitis, Hidradenitis Suppurativa (HS)	1,000	Netherlands	clinicaltrials.gov
September 2, 2026	NCT07800104	Phase 1 Study of QX-4533 in Healthy Volunteers and Patients With Moderate-to-Severe Atopic Dermatitis	QuantX Biosciences, Inc.	Phase 1	Recruiting	Atopic Dermatitis	84	China	clinicaltrials.gov
August 25, 2026	NCT07784816	A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profiles of TLL-018 in Patients With Moderate-to-Severe Atopic Dermatitis	Hangzhou Highlightll Pharmaceutical Co., Ltd	Phase 2/3	Not yet recruiting	Atopic Dermatitis (AD)	390	China	clinicaltrials.gov
August 24, 2026	NCT07783425	A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema	Pfizer	Phase 3	Recruiting	Atopic Dermatitis	1,375	Canada, Japan, Taiwan, United States	clinicaltrials.gov
August 24, 2026	NCT07782476	Study of HXN6005 in Healthy Participants and Patients With Moderate-to-Severe Atopic Dermatitis	Helixon Biotechnology (Suzhou) Co., Ltd	Phase 1/2	Not yet recruiting	Health Adult Subjects, Atopic Dermatitis (AD)	67	China	clinicaltrials.gov
August 24, 2026	NCT07782333	A Study Evaluating TRIV-573 in Atopic Dermatitis	Triveni Bio	Phase 2	Recruiting	Atopic Dermatitis	90	Canada, Ukraine, United States	clinicaltrials.gov
August 17, 2026	NCT07767253	Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD)	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.	Phase 3	Recruiting	Dermatitis, Atopic	246	China	clinicaltrials.gov
August 14, 2026	NCT07765888	A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema	Pfizer	Phase 3	Recruiting	Atopic Dermatitis	375	Japan, United States	clinicaltrials.gov
August 13, 2026	NCT07762833	Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic Dermatitis	Galderma R&D	Phase 3	Recruiting	Atopic Dermatitis	240	China	clinicaltrials.gov
August 10, 2026	NCT07754968	Use of Bifidobacterium Bifidum in Formula-Fed Infants With Colic, With or Without Atopic Dermatitis	University of Roma La Sapienza	Not applicable	Recruiting	Infant Colic, Atopic Dermatitis	64	Italy	clinicaltrials.gov
August 10, 2026	NCT07754786	A Study to Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Participants With Moderate to Severe Atopic Dermatitis	Innovent Biologics (Suzhou) Co. Ltd.	Phase 3	Recruiting	Atopic Dermatitis	520	China	clinicaltrials.gov
August 5, 2026	NCT07748169	An Observational Study of Patients With Dermatologic Disease	Target PharmaSolutions, Inc.	Observational	Not yet recruiting	Vitiligo, Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa (HS)	2,000,000	United States	clinicaltrials.gov
August 5, 2026	NCT07746817	A Study of BYN-001 in Healthy Adults and in Adults With Moderate to Severe Atopic Dermatitis	Bionyra Pharma	Phase 1	Recruiting	Atopic Dermatitis, Healthy Participants	56	Australia	clinicaltrials.gov
August 5, 2026	NCT07746427	Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis	Weill Medical College of Cornell University	Not applicable	Recruiting	Atopic Dermatitis, Eczema	40	United States	clinicaltrials.gov
August 4, 2026	NCT07744516	Clinical Trial to Evaluate the Efficacy and Safety of an Ozonated Oil in Atopic Dermatitis	Laboratorios Ozoaqua	Not applicable	Completed	Atopic Dermatitis (AD), Atopic Dermatitis (Eczema)	50	Spain	clinicaltrials.gov
August 3, 2026	NCT07742241	Efficacy Study of a Repairing Cream in Atopic Dermatitis	Instituto de Investigacion Biotecnologica, Farmaceutica y Medicamentos Huerfanos, S.L.	Not applicable	Completed	Atopic Dermatitis (AD)	116	Spain	clinicaltrials.gov
August 3, 2026	NCT07741838	Effectiveness of Upadacitinib and Biologics for the Achievement of Minimal Disease Activity in Adults With Moderate-to-Severe Atopic...	AbbVie	Observational	Not yet recruiting	Atopic Dermatitis	900		clinicaltrials.gov
July 29, 2026	NCT07734415	Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis	Inmagene LLC	Phase 2	Enrolling by invitation	Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema	400	Canada, United States	clinicaltrials.gov
July 28, 2026	NCT07730788	Reflectance Confocal Microscopy Evaluation of Skin Structure of Patients With Atopic Dermatitis Under Nemolizumab	Hôpitaux Drôme Nord	Observational	Recruiting	Atopic Dermatitis (AD), Atopic Dermatitis (Eczema)	15	France	clinicaltrials.gov
July 20, 2026	NCT07713186	Azithromycin in Atopic Dermatitis	Cairo University	Phase 4	Not yet recruiting	Atopic Dermatitis	40	Egypt	clinicaltrials.gov
July 14, 2026	NCT07703215	NPQ Plus Supplementation for Skin Health and Antioxidant Status	N REMEDIER (M) SDN BHD	Not applicable	Completed	Eczema, Atopic Dermatitis, Skin Health, Fatigue Symptom, Sleep Quality, Antioxidant Capacity, Oxidative Stress	55	Malaysia	clinicaltrials.gov
July 14, 2026	NCT07701447	Efficacy and Tolerability of a Probiotic Ointment	BioGaia AB	Not applicable	Not yet recruiting	Atopic Dermatitis	92		clinicaltrials.gov
July 14, 2026	NCT07700745	A Clinical Trial to Evaluate the Effects of Rejuvaskin Eczema Body Wash and Skin Recovery Cream in Adults With Eczema-Prone Skin	Rejuvaskin	Not applicable	Active not recruiting	Eczema, Atopic Dermatitis, Eczema-Prone Skin	35	United States	clinicaltrials.gov
July 13, 2026	NCT07698756	A Clinical Study of HRS-8797 in Healthy Participants	Chengdu Suncadia Medicine Co., Ltd.	Phase 1	Not yet recruiting	Atopic Dermatitis	74	China	clinicaltrials.gov
July 9, 2026	NCT07693400	Topical Chinese Medicine and Exosome Mechanisms for Atopic Dermatitis	Taiwan Municipal An-Nan Hospital-China Medical University	Phase 2	Active not recruiting	Atopic Dermatitis (AD)	44	Taiwan	clinicaltrials.gov
July 6, 2026	NCT07684937	HL-300 Ointment in Healthy Volunteers	Hangzhou Highlightll Pharmaceutical Co., Ltd	Phase 1	Completed	Atopic Dermatitis	36		clinicaltrials.gov
July 1, 2026	NCT07678645	The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe Itching	RenJi Hospital	Phase 2	Not yet recruiting	Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Atopic Dermatitis (AD)	44	China	clinicaltrials.gov
June 26, 2026	NCT07670676	The Effects of an L-histidine-Based Supplement, Eczema Topical, and Unscented Soap on Children With Eczema	Codex Labs Corporation	Not applicable	Completed	Atopic Dermatitis (Eczema)	40	Poland	clinicaltrials.gov
June 23, 2026	NCT07661979	Opzelura Experience Study	Wake Forest University Health Sciences	Phase 4	Not yet recruiting	Atopic Dermatitis	50	United States	clinicaltrials.gov
June 22, 2026	NCT07659756	Global Healthcare Study on Atopic Dermatitis	Julia Tatjana Maul	Observational	Recruiting	Atopic Dermatitis (AD), Atopic Dermatitis (Eczema)	9,600	Switzerland	clinicaltrials.gov
June 17, 2026	NCT07653386	Clinical Trial of an Ointment in Patients With Mild and Moderate Atopic Dermatitis	VinUniversity	Not applicable	Completed	Mild and Moderate Atopic Dermatitis Patients, Atopic Dermatitis (AD)	90	Vietnam	clinicaltrials.gov
June 12, 2026	NCT07645820	Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares	Castle Biosciences Incorporated	Observational	Recruiting	Atopic Dermatitis	450	United States	clinicaltrials.gov
June 12, 2026	NCT07643766	A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis	Enveda Therapeutics	Phase 2	Recruiting	Atopic Dermatitis	200	United States	clinicaltrials.gov
June 5, 2026	NCT07629778	HL-300 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis	Hangzhou Highlightll Pharmaceutical Co., Ltd	Phase 1/2	Recruiting	Atopic Dermatitis	156	China	clinicaltrials.gov
June 1, 2026	NCT07618234	Dermocosmetic Evaluation of Propolis Ointments in Atopic-Prone Dry Skin	Manara University	Not applicable	Completed	Dry Skin, Atopic Dermatitis, Xerosis Due to Atopic Dermatitis	30	Syria	clinicaltrials.gov
May 29, 2026	NCT07613190	Adjunctive Oral Iron Supplementation in Atopic Dermatitis	Cairo University	Not applicable	Not yet recruiting	Atopic Dermatitis	124		clinicaltrials.gov
May 22, 2026	NCT07604324	A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to...	Novartis Pharmaceuticals	Phase 1	Recruiting	Dermatitis, Atopic	63	Japan	clinicaltrials.gov
May 20, 2026	NCT07599878	Adjunctive Group Psychotherapy for Moderate-to-Severe Atopic Dermatitis: A Pilot Feasibility Study Comparing Two Interventions	Semmelweis University	Not applicable	Completed	Atopic Dermatitis	32	Hungary	clinicaltrials.gov
May 20, 2026	NCT07599813	A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis	Apollo Therapeutics Ltd	Phase 2	Recruiting	Atopic Dermatitis, Atopic, Dermatitis, Dermatitis, Atopic, Dermatologic Disease, Eczema, Eczema Atopic Dermatitis...	280	Bulgaria, Canada, Czechia, Germany, Hungary, Poland, Spain, United States	clinicaltrials.gov
May 20, 2026	NCT07598383	A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in...	Jiangsu vcare pharmaceutical technology co., LTD	Phase 2	Recruiting	Atopic Dermatitis	120	China	clinicaltrials.gov
May 18, 2026	NCT07592585	Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis	Jiangsu vcare pharmaceutical technology co., LTD	Phase 3	Recruiting	Atopic Dermatitis	360	China	clinicaltrials.gov
May 12, 2026	NCT07582237	Long-Term Follow-up Study of FURESTEM-AD in Patients With Atopic Dermatitis(K0106)	Kang Stem Biotech Co., Ltd.	Observational	Active not recruiting	Dermatitis, Atopic	262	South Korea	clinicaltrials.gov
May 11, 2026	NCT07577921	Evaluation of the Efficacy of a Cosmetic Care in Subjects With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments	Pierre Fabre Dermo Cosmetique	Observational	Completed	Atopic Dermatitis	80	France	clinicaltrials.gov
May 7, 2026	NCT07574242	Effect of vitk2 on Atopic Dermatitis Pediatrics Patients	October 6 University	Not applicable	Completed	Atopic Dermatitis	100	Egypt	clinicaltrials.gov
May 7, 2026	NCT07573735	Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis	Zhongda Hospital	Observational	Recruiting	Atopic Dermatitis (Eczema)	80	China	clinicaltrials.gov
May 6, 2026	NCT07568665	Evaluation by Confocal Reflectance Microscopy of the Skin Structure of Patients With Atopic Dermatitis Treated With Tralokinumab Biotherapy.	Hôpitaux Drôme Nord	Observational	Active not recruiting	Atopic Dermatitis (AD), Atopic Dermatitis (Eczema)	15	France	clinicaltrials.gov
May 1, 2026	NCT07560618	Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical...	Integrative Skin Science and Research	Phase 4	Recruiting	ITCH, Atopic Dermatitis	40	United States	clinicaltrials.gov
April 30, 2026	NCT07559773	The ROOT Study: Scaling the 'Standard of Care Plus' Obstetric Nutrition Model to Optimize Maternal and Infant Health	GrowBaby Life Project	Not applicable	Not yet recruiting	Preterm Birth, Preeclampsia, Gestational Diabetes Mellitus (GDM), Small for Gestational Age (SGA), Large for...	500		clinicaltrials.gov
April 24, 2026	NCT07550452	Efficacy and Safety of Switching to Ivarmacitinib in Patients With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to...	Peking University People's Hospital	Not applicable	Not yet recruiting	Atopic Dermatitis (AD)	300		clinicaltrials.gov
April 24, 2026	NCT07549984	A Study of IBI3033 in Moderate-to-Severe Atopic Dermatitis	Innovent Biologics (Suzhou) Co. Ltd.	Phase 1	Not yet recruiting	Atopic Dermatitis	16	China	clinicaltrials.gov
April 24, 2026	NCT07549828	Sebum Metabolomics and Lipidomics for Clinical Applications	National Taiwan University Hospital	Not applicable	Not yet recruiting	Acne, Atopic Dermatitis, Seborrheic Dermatitis, Psoriasis, Healthy Subjects (HS)	200		clinicaltrials.gov
April 24, 2026	NCT07549750	A Dose Escalation Phase 1 Study of HXN5003 in Healthy Participants	Helixon Biotechnology (Suzhou) Co., Ltd	Phase 1	Not yet recruiting	Atopic Dermatitis	28	Australia	clinicaltrials.gov
April 22, 2026	NCT07544862	A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)	Chengdu Kangnuoxing Biopharma,Inc.	Observational	Recruiting	Atopic Dermatitis (AD)	1,000	China	clinicaltrials.gov
April 20, 2026	NCT07540442	A Phase III Study of MG-K10 in Adolescents With Moderate-to-Severe Atopic Dermatitis	Shanghai Mabgeek Biotech.Co.Ltd	Phase 3	Not yet recruiting	Dermatitis, Atopic	180	China	clinicaltrials.gov
April 17, 2026	NCT07537751	Crisaborole vs Fluticasone Propionate in Mild to Moderate Atopic Dermatitis	Noura Abdelmoneim Mohammed Elseessy	Not applicable	Completed	Atopic Dermatitis, Eczema	40	Egypt	clinicaltrials.gov
April 16, 2026	NCT07533851	A Food Effect Study of VC005 Tablets in Healthy Adult Subjects.	Jiangsu vcare pharmaceutical technology co., LTD	Phase 1	Completed	Atopic Dermatitis	31	China	clinicaltrials.gov
April 14, 2026	NCT07527923	First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis	Regeneron Pharmaceuticals	Phase 1	Recruiting	Healthy Volunteer, Atopic Dermatitis	160	Belgium, United States	clinicaltrials.gov
April 13, 2026	NCT07525505	Nigella Sativa Oil for Eczematous Otitis Externa	Bezmialem Vakif University	Not applicable	Recruiting	Eczema/Atopic Dermatitis, Otitis Externa	85	Turkey (Türkiye)	clinicaltrials.gov
April 9, 2026	NCT07519174	A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With...	Foundation University Islamabad	Not applicable	Not yet recruiting	Atopic Dermatitis	72	Pakistan	clinicaltrials.gov
March 31, 2026	NCT07503197	A Study on the Efficacy of 2% Cholesterol Cream in Atopic Dermatitis	Institute of Dermatology, Thailand	Not applicable	Enrolling by invitation	Atopic Dermatitis (AD), Cholesterol, Skin Barrier to Water Loss, Skin Allergy, Eczema Atopic Dermatitis, Trans...	30	Thailand	clinicaltrials.gov
March 23, 2026	NCT07488065	A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	Phase 1	Recruiting	Atopic Dermatitis	90	China	clinicaltrials.gov
March 23, 2026	NCT07487831	The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease	University of California, San Francisco	Phase 4	Recruiting	Atopic Dermatitis (Eczema), Psoriasis	50	United States	clinicaltrials.gov
March 18, 2026	NCT07479615	A Study to Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic Dermatitis	Shanghai Mabgeek Biotech.Co.Ltd	Phase 3	Not yet recruiting	Atopic Dermatitis, Atopic Eczema	498		clinicaltrials.gov
March 12, 2026	NCT07467564	The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis	Sanofi	Observational	Recruiting	Atopic Dermatitis	184	Qatar, Saudi Arabia, United Arab Emirates	clinicaltrials.gov
March 12, 2026	NCT07466940	A Clinical Study to Evaluate SM17 in Healthy Participants	SinoMab BioScience Ltd	Phase 1	Completed	Atopic Dermatitis, Asthma, Inflammatory Bowel Disease	30	China	clinicaltrials.gov
March 6, 2026	NCT07455578	Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease	Seismic Therapeutic AU Pty Ltd	Phase 1	Recruiting	Autoimmune Diseases, Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Psoriasis (PsO), Cutaneous Lupus...	24	Australia	clinicaltrials.gov
March 6, 2026	NCT07453602	Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234	Arcutis Biotherapeutics, Inc.	Phase 1	Recruiting	Atopic Dermatitis (AD), Eczema	125	United States	clinicaltrials.gov
March 4, 2026	NCT07448363	Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica	Caja Costarricense de Seguro Social	Observational	Not yet recruiting	Atopic Dermatitis, Atopic Dermatitis (AD), Atopic Dermatitis (Eczema), Atopic Dermatitis Patients, Atopic Dermatitis /...	50	Costa Rica	clinicaltrials.gov
March 3, 2026	NCT07447063	The Impact of Dietary Salt on the Severity of Eczema	University of California, San Francisco	Phase 4	Recruiting	Eczema, Atopic Dermatitis	40	United States	clinicaltrials.gov
March 3, 2026	NCT07445919	A Clinical Study to Evaluate SM17 for Atopic Dermatitis	SinoMab BioScience Ltd	Phase 2	Recruiting	Atopic Dermatitis	200	China	clinicaltrials.gov
March 3, 2026	NCT07444801	Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact	University Hospital Schleswig-Holstein	Observational	Recruiting	Atopic Dermatitis (Moderate-to-severe) Involving the Genital Region	30	Germany	clinicaltrials.gov
March 2, 2026	NCT07444008	Randomized, Blinded, Placebo-Controlled Evaluation of BioAmicus Complete	NovoNatum Ltd	Not applicable	Recruiting	Infantile Colics, Constipation, Infantile Diarrhea, Atopic Dermatitis	140	Russia	clinicaltrials.gov
March 2, 2026	NCT07441395	Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD	Corvus Pharmaceuticals, Inc.	Phase 2	Recruiting	Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema, Eczema, Atopic	200	United States	clinicaltrials.gov
February 27, 2026	NCT07438509	Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema	Jinnah Postgraduate Medical Centre	Phase 4	Not yet recruiting	Atopic Dermatitis (AD), Atopic Eczema	270		clinicaltrials.gov
February 27, 2026	NCT07437534	Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical...	Hayat Abad Medical Complex, Peshawar	Phase 4	Not yet recruiting	Atopic Dermatitis	148	Pakistan	clinicaltrials.gov
February 25, 2026	NCT07434076	Cross-Sectional Study for an Ocular Imaging-Based Predictive Model of Inflammatory Skin Diseases Grounded in Traditional Chinese Medicine	Shanghai Yueyang Integrated Medicine Hospital	Observational	Not yet recruiting	Psoriasis, Atopic Dermatitis	950		clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Pfizer	11	October 21, 2026
Pierre Fabre Dermo Cosmetique	9	September 24, 2026
Sanofi	7	November 5, 2026
Jiangsu vcare pharmaceutical technology co., LTD	6	May 20, 2026
Innovent Biologics (Suzhou) Co. Ltd.	4	August 10, 2026
Cairo University	4	July 20, 2026
Codex Labs Corporation	4	June 26, 2026
Shanghai Mabgeek Biotech.Co.Ltd	4	April 20, 2026
University of California, San Francisco	4	March 23, 2026
Keymed Biosciences Co.Ltd	4	November 17, 2025
Arcutis Biotherapeutics, Inc.	3	November 4, 2026
Fondazione Policlinico Universitario Agostino Gemelli IRCCS	3	September 29, 2026
Hangzhou Highlightll Pharmaceutical Co., Ltd	3	August 25, 2026
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.	3	August 17, 2026
AbbVie	3	August 3, 2026
Enveda Therapeutics	3	June 12, 2026
Novartis Pharmaceuticals	3	May 22, 2026
SinoMab BioScience Ltd	3	March 12, 2026
National Institute of Allergy and Infectious Diseases (NIAID)	3	December 4, 2025
Akeso	3	January 10, 2025

By phase

Phase	New trials	Latest
Not applicable	58	November 5, 2026
Phase 2	55	November 3, 2026
Observational	48	November 2, 2026
Phase 1	46	November 6, 2026
Phase 3	30	November 5, 2026
Phase 4	16	October 29, 2026
Phase 1/2	5	August 24, 2026
Phase 2/3	3	August 25, 2026
Early phase 1	1	July 3, 2025

By country

Country	New trials	Latest
United States	68	November 4, 2026
China	67	November 6, 2026
Canada	29	August 24, 2026
Poland	26	September 14, 2026
Germany	22	November 5, 2026
France	16	November 2, 2026
Japan	16	August 24, 2026
Spain	15	August 4, 2026
Australia	14	October 29, 2026
Italy	14	August 10, 2026
United Kingdom	12	January 22, 2026
Czechia	10	May 20, 2026
Hungary	9	May 20, 2026
New Zealand	8	September 9, 2026
Brazil	7	November 5, 2026
Taiwan	7	November 3, 2026
Bulgaria	6	May 20, 2026
Egypt	5	July 20, 2026
Argentina	5	November 17, 2025
South Korea	4	May 12, 2026
Belgium	4	April 14, 2026
Denmark	3	September 8, 2026
Netherlands	3	September 4, 2026
Pakistan	3	April 9, 2026
Thailand	3	March 31, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.